Non-operative management for oral cavity carcinoma: Definitive radiation therapy as a potential alternative treatment approach
Ali Hosni,Kevin Chiu,Shao Hui Huang,Wei Xu,Jingyue Huang,Andrew Bayley,Scott V. Bratman,John Cho,Meredith Giuliani,John Kim,Brian O'Sullivan,Jolie Ringash,John Waldron,Anna Spreafico,John R. de Almeida,Eric Monteiro,Ian Witterick,Douglas B. Chepeha,R.W. Gilbert,Jonathan C. Irish,David P. Goldstein,Andrew Hope
DOI: https://doi.org/10.1016/j.radonc.2020.08.013
IF: 6.901
2021-01-01
Radiotherapy and Oncology
Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Purpose</h3><p>To determine the outcomes of oral cavity squamous cell cancer (OSCC) patients treated with non-surgical approach i.e. definitive intensity-modulated radiation therapy (IMRT).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>All OSCC patients treated radically with IMRT (without primary surgery) between 2005-2014 were reviewed in a prospectively collected database. OSCC patients treated with definitive RT received concurrent chemotherapy except for early stage patients or those who declined or were unfit for chemotherapy. The 5-year local, and regional, distant control rates, disease-free, overall, and cancer-specific survival, and late toxicity were analyzed.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Among 1316 OSCC patients treated with curative-intent; 108 patients (8%) received non-operative management due to: medical inoperability (n=14, 13%), surgical unresectability (n=8, 7%), patient declined surgery (n=15, 14%), attempted preservation of oral structure/function in view of required extensive surgery (n=53, 49%) or extensive oropharyngeal involvement (n=18, 17%). Sixty-eight (63%) were cT3-4, 38 (35%) were cN2-3, and 38 (35%) received concurrent chemotherapy. With a median follow-up of 52months, the 5-year local, regional, distant control rate, disease-free, overall, and cancer-specific survival were 78%, 92%, 90%, 42%, 50%, and 76% respectively. Patients with cN2-3 had higher rate of 5-year distant metastasis (24% vs 3%, p=0.001), with detrimental impact on DFS (p=0.03) and OS (p<0.02) on multivariable analysis. Grade ≥3 late toxicity was reported in 9% of patients (most common: grade 3 osteoradionecrosis in 6%).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>Non-operative management of OSCC resulted in a meaningful rate of locoregional control, and could be an alternative curative approach when primary surgery would be declined, unsuitable or unacceptably delayed.</p>
oncology,radiology, nuclear medicine & medical imaging